961086

Sheffield Pharmaceuticals, LLC — FEI 1210513

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 18, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New London, CT (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
1002221 CFR 310.305(a)Failure to develop written procedures
241921 CFR 211.198(a)Complaint Handling Procedure